ALEXANDER MARGARET A.
President and CEO
ALEXANDER MARGARET A. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 2, 2026.
On the most recent filing, ALEXANDER MARGARET A. is listed as President and CEO at Ovid Therapeutics Inc. Inside the rolling window, ALEXANDER MARGARET A. reported no open-market purchases and 1 open-market sale totaling $17K in OVID.
Companies traded
Other insiders at OVID
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$17K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has ALEXANDER MARGARET A. made?
ALEXANDER MARGARET A. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does ALEXANDER MARGARET A. trade?
ALEXANDER MARGARET A. has filed SEC Form 4 disclosures for 1 company, including OVID.
When was ALEXANDER MARGARET A.'s most recent SEC Form 4 filing?
ALEXANDER MARGARET A.'s most recent SEC Form 4 filing on Tracefour is dated Mar 2, 2026.
What is ALEXANDER MARGARET A.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, ALEXANDER MARGARET A. is listed as President and CEO.
What is ALEXANDER MARGARET A.'s total buy and sell value in the current window?
Inside the rolling retention window, ALEXANDER MARGARET A. bought $0 and sold $17K based on SEC Form 4 filings.
What was ALEXANDER MARGARET A.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,656 OVID shares on 2026-02-23, worth $17K, per SEC Form 4 filings.